UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): December 4, 2014
MedAssets, Inc.
(Exact name of registrant as specified in its charter)
| Delaware | 001-33881 | 51-0391128 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
| 100 North Point Center E, Suite 200, Alpharetta, Georgia |
30022 | |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: 678-323-2500
Not Applicable
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
(b) (c) (d)
On December 10, 2014, MedAssets, Inc. (the “Company”) announced that Mr. Michael P. Nolte has been appointed by the Company’s Board of Directors (the “Board”) to serve as the Company’s President, effective December 4, 2014. Mr. Nolte will continue to serve as the Company’s Chief Operating Officer and report directly to Mr. John A. Bardis, the Company’s Chairman of the Board and Chief Executive Officer. Prior to Mr. Nolte’s appointment as President, Mr. Bardis had served as the Company’s President since the Company’s founding in 1999.
Additionally, the Board appointed Mr. Nolte as a Class II director of the Company. Mr. Nolte will serve on the Board until the annual meeting of stockholders to be held in June 2015 and until his successor has been elected and qualified.
| Item 8.01. | Other Events. |
The Company issued a press release on December 10, 2014 announcing the appointment of Mr. Nolte as the Company’s President and member of the Company’s Board. A copy of the press release is attached as Exhibit 99.1 and is being incorporated herein by reference.
| Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits
| Exhibit Number |
Description | |
| 99.1 | Press Release, dated December 10, 2014. | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| MedAssets, Inc. | ||||||
| December 10, 2014 | By: | /s/ Jonathan H. Glenn | ||||
| Name: Jonathan H. Glenn | ||||||
| Title: Executive Vice President, Chief Legal Officer and Corporate Secretary | ||||||
EXHIBIT INDEX
| Exhibit Number |
Description | |
| 99.1 | Press Release, dated December 10, 2014. | |
Exhibit 99.1
MedAssets COO Mike Nolte Promoted to President and
Appointed to Company’s Board of Directors
ATLANTA—December 10, 2014—MedAssets (NASDAQ: MDAS) today announced that Mike Nolte, who currently serves as executive vice president and chief operating officer (COO), was promoted to president and COO and has been appointed to the company’s board of directors, effective immediately. Mr. Nolte will continue to be responsible for leading the company’s operating activities, working with senior management to drive performance excellence and financial results across all business lines.
“MedAssets has grown significantly over the last few years. With more than $700 million in annual revenue and a client base of more than 4,400 acute care and 122,000 alternate site providers, elevating Mike’s role with our organization was a natural evolution of that growth,” said John Bardis, chairman and chief executive officer, MedAssets. “I am extremely grateful to have an individual of Mike’s caliber lead our company’s operating activities while I continue to focus on the strategic progression of MedAssets.”
Mr. Nolte joined MedAssets in March 2012. He most recently served as vice president and general manager of the Americas Services business for GE Healthcare IT, overseeing more than 1,700 staff focused on GE’s healthcare software portfolio that includes revenue cycle, clinical/EHR and digital imaging solutions. Among other roles at GE, Mr. Nolte previously led GE Healthcare’s Enterprise Revenue Cycle software business. Prior to his seven-year GE career, he spent five years with McKinsey & Company, a global management consulting firm.
Before entering the private sector, Mr. Nolte served in the United States Army from 1992 through 1998, ending his military career as a Captain and Company Commander for a rapid deployment medical supply chain and maintenance organization. Mr. Nolte holds a Master’s degree from The University of Chicago Booth School of Business and a Bachelor’s Degree from the University of Notre Dame.
About MedAssets
MedAssets (NASDAQ: MDAS) is a healthcare performance improvement company focused on helping providers realize financial and operational gains so that they can sustainably serve the needs of their community. More than 4,400 hospitals and 122,000 non-acute healthcare providers currently use the company’s evidence-based solutions, best practice processes and analytics to help reduce the total cost of care, enhance operational efficiency, align clinical delivery, and improve revenue performance across the care continuum. For more information, please visit www.medassets.com.
| Media Contact: Robin Wrinn 678.624.7420 rwrinn@medassets.com |
Investor Contact: Robert Borchert 678.248.8194 rborchert@medassets.com |
MDAS/F